HIGHLIGHTS
- who: Jan Buitelaar from the Technion Institute of The of, Australia have published the article: Toward Precision Medicine in ADHD, in the Journal: (JOURNAL)
- future: For future research it will be important to integrate neurocognitive data with other biomarkers across the different levels of analysis. Work in this direction including out of sample validation is needed. Because prior studies of these biomarkers have focused on group effects rather than on diagnostic accuracy and individual prediction more work is needed to define a valid and accurate biomarker profile from this triad. As classical study designs are . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.